11/12/2014 - 1:15pm

Drug Store News caught up with Rite Aid's Robert Thompson to discuss the impact Vaccine Central will have on raising immunization awareness. 

 

11/10/2014 - 11:40am

Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.

11/10/2014 - 11:35am

A national survey from Rite Aid and National Foundation for Infectious Diseases released Monday found that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. 

11/07/2014 - 2:51pm

Teva Pharmaceutical on Friday announced positive findings from a Phase III clinical study that examined the safety and efficacy of Qnasl.

11/07/2014 - 2:37pm

Mylan on Friday announced that it has signed an agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a severe allergic reaction. 

11/07/2014 - 1:30pm

Janssen Therapeutics announced earlier this week that the Food and Drug Administration approved Olysio (simeprevir), a hepatitis C virus NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients as part of a combination antiviral treatment regimen. 

11/06/2014 - 2:41pm

A Belgian healthcare website recently presented the lighter side of researching medical conditions on Google. 

11/05/2014 - 12:52pm

Novo Nordisk on Wednesday announced the relaunch of Cornerstones4Care, an online patient support platform for people living with diabetes.

11/05/2014 - 10:56am

Excellus BlueCross BlueShield patients can now have prescriptions filled at Wegmans, with free home delivery.